FDA warns of potentially fatal arrhythmias with azithromycin

On March 12, 2013, the U.S. Food and Drug Administration (FDA) strengthened the warning for QT interval prolongation and torsades de pointes, a potentially fatal heart rhythm, associated with azithromycin (Zithromax or Zmax). Read more.

Related Articles:

Leave a Reply

You have to agree to the comment policy.